Clinical trial
Schizophrenia Cognition Scale Development: Item Development and Psychometric Validation of a Novel Patient Reported Outcome (PRO) Measure for Research and Clinical Application
NCT02118571 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Schizophrenia Cognition Scale Development: Item Development and Psychometric Validation of a Novel Patient Reported Outcome (PRO) Measure for Research and Clinical Application
- Lead sponsor
- Carelon Research
- Phase
- Observational
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- July 31, 2016
- Enrollment
- 102 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.